Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea.
Int J Mol Sci. 2021 Feb 27;22(5):2407. doi: 10.3390/ijms22052407.
Chinese hamster ovary (CHO) cells are the most valuable expression host for the commercial production of biotherapeutics. Recent trends in recombinant CHO cell-line development have focused on the site-specific integration of transgenes encoding recombinant proteins over random integration. However, the low efficiency of homology-directed repair upon transfection of Cas9, single-guide RNA (sgRNA), and the donor template has limited its feasibility. Previously, we demonstrated that a double-cut donor (DCD) system enables highly efficient CRISPR/Cas9-mediated targeted integration (TI) in CHO cells. Here, we describe several CRISPR/Cas9 vector systems based on DCD templates using a promoter trap-based TI monitoring cell line. Among them, a multi-component (MC) system consisting of an sgRNA/DCD vector and Cas9 expression vector showed an approximate 1.5-fold increase in knock-in (KI) efficiency compared to the previous DCD system, when a systematically optimized relative ratio of sgRNA/DCD and Cas9 vector was applied. Our optimization efforts revealed that concurrently increasing sgRNA and DCD components relative to Cas9 correlated positively with KI efficiency at a single KI site. Furthermore, we explored component bottlenecks, such as effects of sgRNA components and applicability of the MC system on simultaneous double KI. Taken together, we improved the DCD vector design by tailoring plasmid constructs and relative component ratios, and this system can be widely used in the TI strategy of transgenes, particularly in CHO cell line development and engineering.
中国仓鼠卵巢(CHO)细胞是生物制药商业生产中最有价值的表达宿主。最近,重组 CHO 细胞系开发的趋势集中在转染 Cas9、单指导 RNA(sgRNA)和供体模板时,通过基因的特异性整合来编码重组蛋白,而不是随机整合。然而,Cas9 转染时同源定向修复的效率较低,限制了其可行性。以前,我们证明了双切口供体(DCD)系统可在 CHO 细胞中实现高效的 CRISPR/Cas9 介导的靶向整合(TI)。在这里,我们描述了几种基于 DCD 模板的 CRISPR/Cas9 载体系统,使用基于启动子陷阱的 TI 监测细胞系。其中,由 sgRNA/DCD 载体和 Cas9 表达载体组成的多组分(MC)系统与之前的 DCD 系统相比,在应用系统优化的 sgRNA/DCD 和 Cas9 载体相对比例时,敲入(KI)效率提高了约 1.5 倍。我们的优化工作表明,sgRNA 和 DCD 成分相对于 Cas9 的同时增加与单个 KI 位点的 KI 效率呈正相关。此外,我们还探讨了组件瓶颈,例如 sgRNA 组件的影响以及 MC 系统在同时进行双重 KI 中的适用性。总之,我们通过调整质粒构建和相对组件比例改进了 DCD 载体设计,该系统可广泛应用于转基因的 TI 策略,特别是在 CHO 细胞系开发和工程中。